Table 7.

Seventeen subjects, group level correlation testing between delta of number of volumes (ketamine- placebo) and delta clinical symptom scores (ketamine- placebo) by using bivariate Pearson correlation (p < 0.05). No Bonferroni correction applied.

Parameter	Pearson correlation r	Significance level p
Positive symptoms	0.041	0.875
Negative symptoms	0.208	0.423
Sum	0.067	0.797
OBN	0.305	0.797
DED	0.224	0.388
VRS	0.053	0.84
AUA	0.0001	0.999
VIR	0.17	0.948

Abbreviations: “oceanic boundlessness” (OBN), “dread of ego dissolution” (DED), “visionary restructuralization” (VRS), “auditory alterations” (AUA) and “vigilance reduction” (VIR).